Magi Gian Enrico, Mariotti Francesca, Pallotta Lorenzo, Di Cerbo Alessandro, Venanzi Franco Maria
School of Biosciences and Veterinary Medicine, University of Camerino, 62024 Matelica, Italy.
CureLab Oncology Inc., Dedham, MA 02026, USA.
Animals (Basel). 2022 Aug 2;12(15):1964. doi: 10.3390/ani12151964.
The p62 protein, also called sequestosome 1 (SQSTM1), is a ubiquitin-binding scaffold protein. In human oncology, although the interest in the function of this protein is recent, the knowledge is now numerous, but its role in tumorigenesis is not yet clear. This preliminary study aims to evaluate the immunohistochemical expression of p62 in 38 cases of feline mammary carcinoma with different grades of differentiation and in 12 non-neoplastic mammary gland tissues, to assess the expression level and a possible correlation with malignancy. The expression of p62 was statistically higher in carcinoma compared to non-neoplastic mammary glands: 28 feline mammary carcinomas (73.7%) had a high p62 expression score, three (7.9%) had a moderate expression, while seven cases (18.4%) had a low expression. The grade of the differentiation of the carcinoma was not correlated with the p62 expression. This study represents the first approach in feline oncology that correlates p62 expression in feline mammary carcinoma. Our results, although preliminary, are similar to the results of human breast cancer, therefore, also in the cat, p62 could be considered a possible oncotarget.
p62蛋白,也称为聚集体结合蛋白1(SQSTM1),是一种泛素结合支架蛋白。在人类肿瘤学中,尽管对该蛋白功能的研究兴趣是最近才有的,但目前已有大量相关知识,但其在肿瘤发生中的作用尚不清楚。这项初步研究旨在评估p62在38例不同分化程度的猫乳腺癌和12例非肿瘤性乳腺组织中的免疫组化表达,以评估其表达水平以及与恶性肿瘤的可能相关性。与非肿瘤性乳腺相比,p62在癌组织中的表达在统计学上更高:28例猫乳腺癌(73.7%)的p62表达评分高,3例(7.9%)表达中等,7例(18.4%)表达低。癌组织的分化程度与p62表达无关。本研究是猫肿瘤学中首次将p62表达与猫乳腺癌相关联的研究。我们的结果虽然是初步的,但与人类乳腺癌的结果相似,因此,在猫中,p62也可被视为一个可能的肿瘤靶点。